Ulinastatin Reduces Cancer Recurrence after Resection of Hepatic Metastases from Colon Cancer by Inhibiting MMP-9 Activation via the Antifibrinolytic Pathway - Jia, Lin; Li, Jiang-lin; Cai, Wen-song; Xiao, Huan-qing; Shen, Fei; Li, Kun-ping; Xu, Bo; Liu, Qi-cai (BioMed research international, 2013)
Keywords: Animal models; Animals; Cancer; Colleges & universities; Colon; Colon cancer; Colonic Neoplasms - drug therapy; Colonic Neoplasms - pathology; Colonic Neoplasms - surgery; Colorectal cancer; Drug therapy; Glycoproteins - administration & dosage; HCT116 Cells; Humans; Liver cancer; Liver Neoplasms - drug therapy; Liver Neoplasms - secondary; Liver Neoplasms - surgery; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors - administration & dosage; Mice; Neoplasm Recurrence, Local - drug therapy; Neoplasm Recurrence, Local - pathology; Neoplasm Recurrence, Local - surgery; Physiological aspects; Proteases; Relapse; Risk factors; Rodents; China